# FDA recall D-1257-2020

> **B. Braun Medical Inc** · Class I · drug recall initiated 2020-04-18.

## Product

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

## Reason for recall

Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

## Distribution

Product was distributed nationwide within the United States.

## Key facts

- **Recall number:** D-1257-2020
- **Recalling firm:** B. Braun Medical Inc
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-04-18
- **Report date:** 2020-05-06
- **Termination date:** 2021-10-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Irvine, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1257-2020

## Citation

> AI Analytics. FDA recall D-1257-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1257-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*